Travere Therapeutics
TVTX
TVTX
129 hedge funds and large institutions have $934M invested in Travere Therapeutics in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+1
Holders Change %
+0.78%
% of All Funds
2.88%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
22
Increased
46
Reduced
44
Closed
21
Calls
$9.46M
Puts
$5.18M
Net Calls
+$4.28M
Net Calls Change
-$341K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$14.8M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$7.68M |
| 3 |
Two Sigma Investments
New York
|
+$4.85M |
| 4 |
D.E. Shaw & Co
New York
|
+$4.13M |
| 5 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$4M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18.5M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$13.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$11.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.61M |
| 5 |
Millennium Management
New York
|
-$5.16M |
